Human Apolipoprotein C2 VLDL Purified Lyophilized

<strong>Human Apolipoprotein C2 VLDL Purified Lyophilized</strong>_x000D_ <strong>Catalog number:</strong> B2016114_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -70¬∞C_x000D_ <strong>Keywords:</strong> Human Apolipoprotein C2 VLDL Purified Lyophilized_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Dedoussis GV. Apolipoprotein polymorphisms and familial hypercholesterolemia Pharmacogenomics. 2007 Sep;8(9):1179-89._x000D_ 2: Kamboh MI, Aston CE, Hamman RF. DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile Atherosclerosis. 2000 Sep;152(1):193-201._x000D_ 3: Serveaux Dancer M, Di Filippo M, Marmontel O, Val√©ro R, Piombo Rivarola MDC, Peretti N, Caussy C, Krempf M, Verg√®s B, Mahl M, Mar√ßais C, Moulin P, Charri√®re S. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia J Clin Lipidol. 2018 Sep-Oct;12(5):1244-1252._x000D_ 4: Kovrov O, Landfors F, Saar-Kovrov V, N√§slund U, Olivecrona G. Lipoprotein size is a main determinant for the rate of hydrolysis by exogenous LPL in human plasma J Lipid Res. 2022 Jan;63(1):100144._x000D_ 5: Lorenzatti AJ, Monsalvo ML, L√≥pez JAG, Wang H, Rosenson RS. Effects of evolocumab in individuals with type 2 diabetes with and without atherogenic dyslipidemia: An analysis from BANTING and BERSON Cardiovasc Diabetol. 2021 Apr 30;20(1):94._x000D_ 6: Benevides LJ, Carvalho DS, Andrade RF, Bomfim GC, Fernandes FM. Evolutionary analysis of apolipoprotein E by Maximum Likelihood and complex network methods Genet Mol Biol. 2016 Oct-Dec;39(4):665-673._x000D_ 7: Lacerda GS, Medeiros T, Ros√°rio NFD, Peralta RHS, Cabral-Castro MJ, Esberard EBC, Andrade TG, Xavier AR, Silva AA. Exploring lipid and apolipoprotein levels in chronic hepatitis C patients according to their response to antiviral treatment Clin Biochem. 2018 Sep;60:17-23._x000D_ 8: Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia Metabolism. 2008 Jun;57(6):796-801._x000D_ 9: Sheridan DA, Price DA, Schmid ML, Toms GL, Donaldson P, Neely D, Bassendine MF. Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin Aliment Pharmacol Ther. 2009 Jun 15;29(12):1282-90._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/26092865">10: Apro J, Parini P, Broijers√©n A, Angelin B, Rudling M. Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients J Lipid Res. 2015 Aug;56(8):1633-9. </a>_x000D_ _x000D_ <strong>Products Related to Human Apolipoprotein C2 VLDL Purified Lyophilized can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>